ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,051.41
      -0.21%
      US Tech 100
      17,272.80
      0.18%
      Dow Jones
      37,798.97
      0.17%
      Brent Oil
      89.56
      -0.35%
      Bitcoin
      63,803.87
      0.60%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Cel Sci Corporation New (CVM)

      7. Cel Sci Corporation New (CVM) News

      CVM

      Cel Sci (CVM)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:CVM
      DateTimeSourceHeadlineSymbolCompany
      12:52PMiHub NewswireFeaturedCannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
      03/19/20249:00AMBusiness WireCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in ImmunologyAMEX:CVMCel Sci Corporation New
      03/07/202411:33AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:CVMCel Sci Corporation New
      03/07/202411:33AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:CVMCel Sci Corporation New
      03/07/202411:31AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:CVMCel Sci Corporation New
      03/06/20248:45AMBusiness WireCEL-SCI Corporation Issues Letter to ShareholdersAMEX:CVMCel Sci Corporation New
      02/15/20248:00AMBusiness WireCEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial ResultsAMEX:CVMCel Sci Corporation New
      02/14/20244:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CVMCel Sci Corporation New
      02/13/202412:00PMBusiness WireCEL-SCI Announces Closing of $7.75 Million Public Offering of Common StockAMEX:CVMCel Sci Corporation New
      02/09/20248:44AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:CVMCel Sci Corporation New
      02/09/20248:30AMBusiness WireCEL-SCI Announces Pricing of $7.75 Million Public Offering of Common StockAMEX:CVMCel Sci Corporation New
      02/06/20249:00AMBusiness WireCEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer DrugAMEX:CVMCel Sci Corporation New
      01/31/20249:00AMBusiness WireEuropean Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®AMEX:CVMCel Sci Corporation New
      01/02/20249:06AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
      01/02/20249:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
      01/02/20249:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
      12/22/20234:01PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:CVMCel Sci Corporation New
      12/22/20238:00AMBusiness WireCEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate DevelopmentsAMEX:CVMCel Sci Corporation New
      12/21/20234:15PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:CVMCel Sci Corporation New
      12/04/20238:30AMBusiness WireUK’S National Institute for Health and Care Excellence (NICE) Selects CEL-SCI’s Multikine as Potential New Standard of Care for Head & Neck CancerAMEX:CVMCel Sci Corporation New
      11/20/20235:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
      11/20/20234:15PMBusiness WireCEL-SCI Announces Closing of $5 Million Public Offering of Common StockAMEX:CVMCel Sci Corporation New
      11/16/20238:39AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:CVMCel Sci Corporation New
      11/16/20238:30AMBusiness WireCEL-SCI Announces Pricing of $5 Million Offering of Common StockAMEX:CVMCel Sci Corporation New
      10/30/20235:01PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
      10/30/20239:20AMBusiness WireCEL-SCI Issues Letter to ShareholdersAMEX:CVMCel Sci Corporation New
      10/24/202310:18AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
      10/24/20238:00AMBusiness WireCEL-SCI Releases Video Detailing Recent Phase 3 Findings & its Plans to Seek Immediate Regulatory ApprovalsAMEX:CVMCel Sci Corporation New
      10/23/20239:15AMBusiness Wire5-Year Head & Neck Cancer Survival Increased From 45% to 73% in CEL-SCI’s Target Population, Cutting Risk of Death in Half, as Presented at Leading Cancer Conference ESMO 2023AMEX:CVMCel Sci Corporation New
      10/19/20238:00AMBusiness WireCEL-SCI Readies Its Multikine Manufacturing Facility for Commercial Scale ProductionAMEX:CVMCel Sci Corporation New
       Showing the most relevant articles for your search:AMEX:CVM